Accuray to Announce Financial Results for First Quarter
Accuray Incorporated (NASDAQ: ARAY) is gearing up to release its financial outcomes for the first quarter of fiscal year 2026, which concluded on September 30, 2025. The announcement is scheduled for November 5, 2025, with a conference call following at 1:30 p.m. Pacific Time.
Join the Conference Call
Investors and stakeholders are encouraged to participate in this informative call. The dial-in numbers for the call are 1-833-316-0563 for USA participants or 1-412-317-5747 for those calling internationally. A replay of the concall will be made available approximately one hour after it concludes, with access for one week. The replay can be reached by calling 1-855-669-9658 for USA participants or 1-412-317-0088 for international participants, using conference ID 7403898.
How to Access the Live Webcast
A live webcast will also be accessible from the Investor Relations section of Accuray's website. Listeners can visit the company's investor page to access the live stream and replay of the discussion, ensuring they stay informed about the latest financial developments.
Commitment to Radiation Therapy Innovations
Accuray is at the forefront of enhancing the power of radiation therapy designed to improve countless lives. The company is dedicated to creating groundbreaking, market-leading solutions that facilitate radiation treatments for both complex and straightforward cases alike. This dedication informs their mission to better meet various patient needs.
Continuous Innovations in Healthcare
The firm emphasizes ongoing advancements in radiation therapy for various applications, including oncology and neuro-radiosurgery. By collaborating with healthcare professionals and administrators, Accuray is empowering them to help patients achieve quicker recovery times and return to their daily lives.
About Accuray
Headquartered in Madison, Wisconsin, Accuray operates with a global presence. The company is staunchly focused on advancing treatment methodologies through technological innovations. Their efforts have led to the development of unique treatment capabilities in the field of radiation therapy.
Get Involved with Accuray
For those interested in learning more about Accuray's innovative solutions and commitment to patient care, their official website provides a wealth of information.
Investor and Public Relations Contacts
For investor inquiries, Aman Patel, CFA, is the key contact in Investor Relations at ICR Healthcare. Interested parties can reach out to him for further discussions on investment opportunities or financial performances.
Additionally, Beth Kaplan serves as the Public Relations Director for the company, managing media relations and public inquiries.
Frequently Asked Questions
What date will Accuray report its financial results?
Accuray will report its financial results for the first quarter on November 5, 2025.
How can I listen to the earnings call?
You can listen to the near live earnings call by dialing in at 1-833-316-0563 for the USA or 1-412-317-5747 for international callers.
Is there a way to access a replay of the call?
Yes, a replay will be available about an hour after the call concludes, accessible for one week thereafter.
What is Accuray's primary focus?
Accuray is focused on providing innovative solutions in radiation therapy to meet diverse patient needs.
Where is Accuray located?
Accuray is headquartered in Madison, Wisconsin, with facilities around the world.